NLA Resources
Knowledge Center
Membership Resources
Join the National Lipid Association, focused on enhancing the science and practice of lipidology to promote optimal cardiometabolic health.
After making your filter selections, please scroll down to see results.
Top Line Results from the Phase 3 Lp(a)HORIZON Trial
On September 4, 2026, Novartis announced the topline results of its phase 3 Lp(a)HORIZON trial. Novartis shared that while pelacarsen lowered lipoprotein(a) [Lp(a)] levels, the trial failed to reduce the risk of major adverse cardiovascular…
Make Your Voice Heard: Support LDL-C Quality Measurement in the CMS CY 2027 Physician Fee Schedule
The Centers for Medicare & Medicaid Services (CMS) is accepting public comments on the Calendar Year (CY) 2027 Medicare Physician Fee Schedule Proposed Rule, and…
Update on Familial Hypercholesterolemia: An Expert Clinical Consensus from the National Lipid Association
Update on Familial Hypercholesterolemia: An Expert Clinical Consensus from the National Lipid Association
LDL Cholesterol Management Simplified in Adults—Lower for Longer is Better: Guidance from the National Lipid Association
LDL cholesterol management simplified in adults—lower for longer is better: Guidance from the National Lipid Association
Multidisciplinary Teams in Clinical Lipidology and Cardiometabolic Care: A National Lipid Association Expert Clinical Review
Multidisciplinary teams in clinical lipidology and cardiometabolic care: A National Lipid Association Expert Clinical Review
Managing Hypercholesterolemia in Adults Older Than 75 Years Without a History of Atherosclerotic Cardiovascular Disease: An Expert Clinical Consensus from the National Lipid Association and the American Geriatrics Society
Managing Hypercholesterolemia in Adults Older Than 75 Years Without a History of Atherosclerotic Cardiovascular Disease: An Expert Clinical Consensus from the National Lipid Association and…
Recognition and Management of Persistent Chylomicronemia: A Joint Expert Clinical Consensus by the National Lipid Association and the American Society for Preventive Cardiology
Recognition and Management of Persistent Chylomicronemia: A Joint Expert Clinical Consensus by the National Lipid Association and the American Society for Preventive Cardiology
Familial Chylomicronemia Syndrome: An Expert Clinical Review from the National Lipid Association
Familial Chylomicronemia Syndrome: An Expert Clinical Review from the National Lipid Association